Midgard Science

Labs / CDMO: development & manufacturing

Amphix Bio

Chicago, IL, United States · amphixbio.com

GMP

Amphix Bio develops peptide therapeutics based on supramolecular chemistry for degenerative diseases and traumatic injury. Its work is centered on the Supramolecular Therapeutic Peptide (STP) platform, which aims to modulate cell and tissue biology and activate regenerative pathways.

They take quote requests by email.

What they offer

  • Supramolecular Therapeutic Peptide (STP) platform development

    Develops a peptide therapeutic platform using supramolecular chemistry to create dynamic 3D scaffolds that activate regenerative signaling.

  • Peptide therapeutic development

    Develops peptide therapeutics intended to treat degenerative diseases and promote healing after traumatic injury.

What they work on

Modalities
Peptide, Cell therapy
Therapeutic areas
degenerative diseases, traumatic injury, stroke, spinal cord injury, cartilage repair
Quality
FDA Orphan Drug Designation (acute spinal cord injury therapeutic)
Address
400 North Aberdeen Street Suite 900 Chicago, IL 60642

Similar labs. 3C Therapeutics, Artis, Aurigene Pharmaceutical Services, Crystal NAX

Found in a contract services directory. Listing built from amphixbio.com. Work here? Claim this listing.

Amphix Bio · Midgard Science